{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T09:23:13Z","timestamp":1777195393784,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jneuroim.2022.577955","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T20:25:24Z","timestamp":1661631924000},"page":"577955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Effect of tacrolimus on soluble costimulatory molecules in patients with refractory myasthenia gravis"],"prefix":"10.1016","volume":"372","author":[{"given":"Hui","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanshi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chongbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2022.577955_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-981-32-9717-3_1","article-title":"Co-signal molecules in T-cell activation\u202f: historical overview and perspective","volume":"1189","author":"Azuma","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jneuroim.2022.577955_bb0010","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2022.577955_bb0015","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1749-6632.1998.tb11015.x","article-title":"Reliability testing of the quantitative myasthenia gravis score","volume":"841","author":"Barohn","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2022.577955_bb0020","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/14728222.2020.1790529","article-title":"Prognostic relevance of programmed cell death protein 1\/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach","volume":"24","author":"Berardi","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jneuroim.2022.577955_bb0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mus.21883","article-title":"The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravis","volume":"43","author":"Burns","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2022.577955_bb0030","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3389\/fimmu.2020.00809","article-title":"CD4(+) T cells of myasthenia gravis patients are characterized by increased IL-21, IL-4, and IL-17A productions and higher presence of PD-1 and ICOS","volume":"11","author":"Cebi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577955_bb0035","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.it.2013.07.003","article-title":"B7 family checkpoint regulators in immune regulation and disease","volume":"34","author":"Ceeraz","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jneuroim.2022.577955_bb0040","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/ene.13652","article-title":"Dose optimization of tacrolimus with therapeutic drug monitoring and CYP3A5 polymorphism in patients with myasthenia gravis","volume":"25","author":"Chen","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577955_bb0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2567.2003.01716.x","article-title":"Potential role of soluble CD40 in the humoral immune response impairment of uraemic patients","volume":"110","author":"Contin","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.jneuroim.2022.577955_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108515","article-title":"The IL-2 - IL-2 receptor pathway in health and disease: the role of the soluble IL-2 receptor","volume":"218","author":"Damoiseaux","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577955_bb0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/35051100","article-title":"ICOS co-stimulatory receptor is essential for T-cell activation and function","volume":"409","author":"Dong","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2022.577955_bb0060","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/physrev.00045.2017","article-title":"The TNF family of ligands and receptors: communication modules in the immune system and beyond","volume":"99","author":"Dostert","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jneuroim.2022.577955_bb0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jneuroim.2022.577955_bb0070","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jneuroim.2007.01.007","article-title":"Soluble costimulatory factors sCD28, sCD80, sCD86 and sCD152 in relation to other markers of immune activation in patients with myasthenia gravis","volume":"185","author":"Kakoulidou","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2022.577955_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.587460","article-title":"Soluble PD-1: predictive, prognostic, and therapeutic value for cancer immunotherapy","volume":"11","author":"Khan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577955_bb0080","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1615\/CritRevImmunol.v37.i2-6.100","article-title":"Functions of CD40 and its ligand, gp39 (CD40L)","volume":"37","author":"Laman","year":"2017","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577955_bb0085","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/a-0647-6860","article-title":"Elevation in circulating soluble CD40 ligand concentrations in type 2 diabetic retinopathy and association with its severity","volume":"128","author":"Lamine","year":"2020","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.jneuroim.2022.577955_bb0090","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.transproceed.2007.11.074","article-title":"Regulatory effect of FK506 on CD152 and PD-1 in the liver allorecipients","volume":"40","author":"Li","year":"2008","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.jneuroim.2022.577955_bb0095","doi-asserted-by":"crossref","DOI":"10.1177\/1756285617749134","article-title":"When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies","volume":"11","author":"Mantegazza","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jneuroim.2022.577955_bb0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jneuroim.2018.01.001","article-title":"Soluble CD40 ligand disrupts the blood-brain barrier and exacerbates inflammation in experimental autoimmune encephalomyelitis","volume":"316","author":"Masuda","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2022.577955_bb0105","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3892\/mmr.2016.5968","article-title":"Expression of soluble programmed death-1 protein in peripheral blood regulatory T cells and its effects on rheumatoid arthritis progression","volume":"15","author":"Ren","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jneuroim.2022.577955_bb0110","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1196\/annals.1254.057","article-title":"A simple manual muscle test for myasthenia gravis: validation and comparison with the QMG score","volume":"998","author":"Sanders","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2022.577955_bb0115","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/CND.0000000000000034","article-title":"Treatment-refractory myasthenia gravis","volume":"15","author":"Silvestri","year":"2014","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"10.1016\/j.jneuroim.2022.577955_bb0120","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35051113","article-title":"ICOS is essential for effective T-helper-cell responses","volume":"409","author":"Tafuri","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2022.577955_bb0125","article-title":"Regulatory effect of PD1\/PD-ligand 1 (PD-L1) on Treg cells in patients with idiopathic pulmonary fibrosis","volume":"27","author":"Wang","year":"2021","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.jneuroim.2022.577955_bb0130","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","article-title":"Myasthenia gravis activities of daily living profile","volume":"52","author":"Wolfe","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577955_bb0135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.clim.2019.07.011","article-title":"Unbalanced expression of membrane-bound and soluble inducible costimulator and programmed cell death 1 in patients with myasthenia gravis","volume":"207","author":"Yan","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577955_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577402","article-title":"The treatment effect on peripheral B cell markers in antibody positive myasthenia gravis patients","volume":"349","author":"Yilmaz","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2022.577955_bb0145","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.jocn.2013.11.046","article-title":"Double filtration plasmapheresis benefits myasthenia gravis patients through an immunomodulatory action","volume":"21","author":"Zhang","year":"2014","journal-title":"J. Clin. Neurosci."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822001503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822001503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:41:05Z","timestamp":1759048865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572822001503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":29,"alternative-id":["S0165572822001503"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577955","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of tacrolimus on soluble costimulatory molecules in patients with refractory myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577955","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577955"}}